Peptide therapy refers to restoring the amount of peptides to stimulate the cellular regeneration system in the body, and can be an excellent complement to small molecule and biotherapeutics as a treatment option under certain conditions. The most common uses of peptide therapy are to help build muscle and reduce fat, increase energy, improve sexual function, and reduce gastrointestinal and musculoskeletal inflammation. The most common prescription peptide combinations naturally boost growth hormone for better recovery. Peptides were initially used only for diagnostics and hormone therapy; however, as technology has advanced, they are now also widely used to treat cancer and chronic metabolic diseases. Peptides are also used in cosmeceutical operations to slow down the skin's aging process.
This report aims to provide a comprehensive presentation of the global market for Peptide Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peptide Therapy. This report contains market size and forecasts of Peptide Therapy in global, including the following market information:
Global Peptide Therapy Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global Peptide Therapy Market Sales, 2018-2023, 2024-2032, (K Units)
Global top five Peptide Therapy companies in 2022 (%)
The global Peptide Therapy market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Parenteral Route of Administration Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Peptide Therapy include Eli Lilly, AstraZeneca, Merck, Ipsen, Novo Nordisk, Teva Pharmaceutical Industries, Abbott Laboratories, Sanofi and J & J, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Peptide Therapy manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Peptide Therapy Market, by Type, 2018-2023, 2024-2032 ($ Millions) & (K Units)
Global Peptide Therapy Market Segment Percentages, by Type, 2022 (%)
Parenteral Route of Administration
Mucosal Route of Administration
Oral Route of Administration
Transdermal Route of Administration
Global Peptide Therapy Market, by Application, 2018-2023, 2024-2032 ($ Millions) & (K Units)
Global Peptide Therapy Market Segment Percentages, by Application, 2022 (%)
Cancer
Cardiovascular Diseases
Gastrointestinal Disorders
Metabolic Disorders
Others
Global Peptide Therapy Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions) & (K Units)
Global Peptide Therapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Peptide Therapy revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Peptide Therapy revenues share in global market, 2022 (%)
Key companies Peptide Therapy sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Peptide Therapy sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Eli Lilly
AstraZeneca
Merck
Ipsen
Novo Nordisk
Teva Pharmaceutical Industries
Abbott Laboratories
Sanofi
J & J
Novartis
Takeda
Ferring
AbbVie
Heinis
Hemmo
Emcure Pharmaceutical
Cipla
Gland Pharma
Troikaa Pharmaceuticals
Biological E
Outline of Major Chapters:
Chapter 1: Introduces the definition of Peptide Therapy, market overview.
Chapter 2: Global Peptide Therapy market size in revenue and volume.
Chapter 3: Detailed analysis of Peptide Therapy manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Peptide Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Peptide Therapy capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Peptide Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Peptide Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Peptide Therapy Overall Market Size
2.1 Global Peptide Therapy Market Size: 2022 VS 2032
2.2 Global Peptide Therapy Revenue, Prospects & Forecasts: 2018-2032
2.3 Global Peptide Therapy Sales: 2018-2032
3 Company Landscape
3.1 Top Peptide Therapy Players in Global Market
3.2 Top Global Peptide Therapy Companies Ranked by Revenue
3.3 Global Peptide Therapy Revenue by Companies
3.4 Global Peptide Therapy Sales by Companies
3.5 Global Peptide Therapy Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Peptide Therapy Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Peptide Therapy Product Type
3.8 Tier 1, Tier 2 and Tier 3 Peptide Therapy Players in Global Market
3.8.1 List of Global Tier 1 Peptide Therapy Companies
3.8.2 List of Global Tier 2 and Tier 3 Peptide Therapy Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Peptide Therapy Market Size Markets, 2022 & 2032
4.1.2 Parenteral Route of Administration
4.1.3 Mucosal Route of Administration
4.1.4 Oral Route of Administration
4.1.5 Transdermal Route of Administration
4.2 By Type - Global Peptide Therapy Revenue & Forecasts
4.2.1 By Type - Global Peptide Therapy Revenue, 2018-2023
4.2.2 By Type - Global Peptide Therapy Revenue, 2024-2032
4.2.3 By Type - Global Peptide Therapy Revenue Market Share, 2018-2032
4.3 By Type - Global Peptide Therapy Sales & Forecasts
4.3.1 By Type - Global Peptide Therapy Sales, 2018-2023
4.3.2 By Type - Global Peptide Therapy Sales, 2024-2032
4.3.3 By Type - Global Peptide Therapy Sales Market Share, 2018-2032
4.4 By Type - Global Peptide Therapy Price (Manufacturers Selling Prices), 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Peptide Therapy Market Size, 2022 & 2032
5.1.2 Cancer
5.1.3 Cardiovascular Diseases
5.1.4 Gastrointestinal Disorders
5.1.5 Metabolic Disorders
5.1.6 Others
5.2 By Application - Global Peptide Therapy Revenue & Forecasts
5.2.1 By Application - Global Peptide Therapy Revenue, 2018-2023
5.2.2 By Application - Global Peptide Therapy Revenue, 2024-2032
5.2.3 By Application - Global Peptide Therapy Revenue Market Share, 2018-2032
5.3 By Application - Global Peptide Therapy Sales & Forecasts
5.3.1 By Application - Global Peptide Therapy Sales, 2018-2023
5.3.2 By Application - Global Peptide Therapy Sales, 2024-2032
5.3.3 By Application - Global Peptide Therapy Sales Market Share, 2018-2032
5.4 By Application - Global Peptide Therapy Price (Manufacturers Selling Prices), 2018-2032
6 Sights by Region
6.1 By Region - Global Peptide Therapy Market Size, 2022 & 2032
6.2 By Region - Global Peptide Therapy Revenue & Forecasts
6.2.1 By Region - Global Peptide Therapy Revenue, 2018-2023
6.2.2 By Region - Global Peptide Therapy Revenue, 2024-2032
6.2.3 By Region - Global Peptide Therapy Revenue Market Share, 2018-2032
6.3 By Region - Global Peptide Therapy Sales & Forecasts
6.3.1 By Region - Global Peptide Therapy Sales, 2018-2023
6.3.2 By Region - Global Peptide Therapy Sales, 2024-2032
6.3.3 By Region - Global Peptide Therapy Sales Market Share, 2018-2032
6.4 North America
6.4.1 By Country - North America Peptide Therapy Revenue, 2018-2032
6.4.2 By Country - North America Peptide Therapy Sales, 2018-2032
6.4.3 US Peptide Therapy Market Size, 2018-2032
6.4.4 Canada Peptide Therapy Market Size, 2018-2032
6.4.5 Mexico Peptide Therapy Market Size, 2018-2032
6.5 Europe
6.5.1 By Country - Europe Peptide Therapy Revenue, 2018-2032
6.5.2 By Country - Europe Peptide Therapy Sales, 2018-2032
6.5.3 Germany Peptide Therapy Market Size, 2018-2032
6.5.4 France Peptide Therapy Market Size, 2018-2032
6.5.5 U.K. Peptide Therapy Market Size, 2018-2032
6.5.6 Italy Peptide Therapy Market Size, 2018-2032
6.5.7 Russia Peptide Therapy Market Size, 2018-2032
6.5.8 Nordic Countries Peptide Therapy Market Size, 2018-2032
6.5.9 Benelux Peptide Therapy Market Size, 2018-2032
6.6 Asia
6.6.1 By Region - Asia Peptide Therapy Revenue, 2018-2032
6.6.2 By Region - Asia Peptide Therapy Sales, 2018-2032
6.6.3 China Peptide Therapy Market Size, 2018-2032
6.6.4 Japan Peptide Therapy Market Size, 2018-2032
6.6.5 South Korea Peptide Therapy Market Size, 2018-2032
6.6.6 Southeast Asia Peptide Therapy Market Size, 2018-2032
6.6.7 India Peptide Therapy Market Size, 2018-2032
6.7 South America
6.7.1 By Country - South America Peptide Therapy Revenue, 2018-2032
6.7.2 By Country - South America Peptide Therapy Sales, 2018-2032
6.7.3 Brazil Peptide Therapy Market Size, 2018-2032
6.7.4 Argentina Peptide Therapy Market Size, 2018-2032
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Peptide Therapy Revenue, 2018-2032
6.8.2 By Country - Middle East & Africa Peptide Therapy Sales, 2018-2032
6.8.3 Turkey Peptide Therapy Market Size, 2018-2032
6.8.4 Israel Peptide Therapy Market Size, 2018-2032
6.8.5 Saudi Arabia Peptide Therapy Market Size, 2018-2032
6.8.6 UAE Peptide Therapy Market Size, 2018-2032
7 Manufacturers & Brands Profiles
7.1 Eli Lilly
7.1.1 Eli Lilly Company Summary
7.1.2 Eli Lilly Business Overview
7.1.3 Eli Lilly Peptide Therapy Major Product Offerings
7.1.4 Eli Lilly Peptide Therapy Sales and Revenue in Global (2018-2023)
7.1.5 Eli Lilly Key News & Latest Developments
7.2 AstraZeneca
7.2.1 AstraZeneca Company Summary
7.2.2 AstraZeneca Business Overview
7.2.3 AstraZeneca Peptide Therapy Major Product Offerings
7.2.4 AstraZeneca Peptide Therapy Sales and Revenue in Global (2018-2023)
7.2.5 AstraZeneca Key News & Latest Developments
7.3 Merck
7.3.1 Merck Company Summary
7.3.2 Merck Business Overview
7.3.3 Merck Peptide Therapy Major Product Offerings
7.3.4 Merck Peptide Therapy Sales and Revenue in Global (2018-2023)
7.3.5 Merck Key News & Latest Developments
7.4 Ipsen
7.4.1 Ipsen Company Summary
7.4.2 Ipsen Business Overview
7.4.3 Ipsen Peptide Therapy Major Product Offerings
7.4.4 Ipsen Peptide Therapy Sales and Revenue in Global (2018-2023)
7.4.5 Ipsen Key News & Latest Developments
7.5 Novo Nordisk
7.5.1 Novo Nordisk Company Summary
7.5.2 Novo Nordisk Business Overview
7.5.3 Novo Nordisk Peptide Therapy Major Product Offerings
7.5.4 Novo Nordisk Peptide Therapy Sales and Revenue in Global (2018-2023)
7.5.5 Novo Nordisk Key News & Latest Developments
7.6 Teva Pharmaceutical Industries
7.6.1 Teva Pharmaceutical Industries Company Summary
7.6.2 Teva Pharmaceutical Industries Business Overview
7.6.3 Teva Pharmaceutical Industries Peptide Therapy Major Product Offerings
7.6.4 Teva Pharmaceutical Industries Peptide Therapy Sales and Revenue in Global (2018-2023)
7.6.5 Teva Pharmaceutical Industries Key News & Latest Developments
7.7 Abbott Laboratories
7.7.1 Abbott Laboratories Company Summary
7.7.2 Abbott Laboratories Business Overview
7.7.3 Abbott Laboratories Peptide Therapy Major Product Offerings
7.7.4 Abbott Laboratories Peptide Therapy Sales and Revenue in Global (2018-2023)
7.7.5 Abbott Laboratories Key News & Latest Developments
7.8 Sanofi
7.8.1 Sanofi Company Summary
7.8.2 Sanofi Business Overview
7.8.3 Sanofi Peptide Therapy Major Product Offerings
7.8.4 Sanofi Peptide Therapy Sales and Revenue in Global (2018-2023)
7.8.5 Sanofi Key News & Latest Developments
7.9 J & J
7.9.1 J & J Company Summary
7.9.2 J & J Business Overview
7.9.3 J & J Peptide Therapy Major Product Offerings
7.9.4 J & J Peptide Therapy Sales and Revenue in Global (2018-2023)
7.9.5 J & J Key News & Latest Developments
7.10 Novartis
7.10.1 Novartis Company Summary
7.10.2 Novartis Business Overview
7.10.3 Novartis Peptide Therapy Major Product Offerings
7.10.4 Novartis Peptide Therapy Sales and Revenue in Global (2018-2023)
7.10.5 Novartis Key News & Latest Developments
7.11 Takeda
7.11.1 Takeda Company Summary
7.11.2 Takeda Peptide Therapy Business Overview
7.11.3 Takeda Peptide Therapy Major Product Offerings
7.11.4 Takeda Peptide Therapy Sales and Revenue in Global (2018-2023)
7.11.5 Takeda Key News & Latest Developments
7.12 Ferring
7.12.1 Ferring Company Summary
7.12.2 Ferring Peptide Therapy Business Overview
7.12.3 Ferring Peptide Therapy Major Product Offerings
7.12.4 Ferring Peptide Therapy Sales and Revenue in Global (2018-2023)
7.12.5 Ferring Key News & Latest Developments
7.13 AbbVie
7.13.1 AbbVie Company Summary
7.13.2 AbbVie Peptide Therapy Business Overview
7.13.3 AbbVie Peptide Therapy Major Product Offerings
7.13.4 AbbVie Peptide Therapy Sales and Revenue in Global (2018-2023)
7.13.5 AbbVie Key News & Latest Developments
7.14 Heinis
7.14.1 Heinis Company Summary
7.14.2 Heinis Business Overview
7.14.3 Heinis Peptide Therapy Major Product Offerings
7.14.4 Heinis Peptide Therapy Sales and Revenue in Global (2018-2023)
7.14.5 Heinis Key News & Latest Developments
7.15 Hemmo
7.15.1 Hemmo Company Summary
7.15.2 Hemmo Business Overview
7.15.3 Hemmo Peptide Therapy Major Product Offerings
7.15.4 Hemmo Peptide Therapy Sales and Revenue in Global (2018-2023)
7.15.5 Hemmo Key News & Latest Developments
7.16 Emcure Pharmaceutical
7.16.1 Emcure Pharmaceutical Company Summary
7.16.2 Emcure Pharmaceutical Business Overview
7.16.3 Emcure Pharmaceutical Peptide Therapy Major Product Offerings
7.16.4 Emcure Pharmaceutical Peptide Therapy Sales and Revenue in Global (2018-2023)
7.16.5 Emcure Pharmaceutical Key News & Latest Developments
7.17 Cipla
7.17.1 Cipla Company Summary
7.17.2 Cipla Business Overview
7.17.3 Cipla Peptide Therapy Major Product Offerings
7.17.4 Cipla Peptide Therapy Sales and Revenue in Global (2018-2023)
7.17.5 Cipla Key News & Latest Developments
7.18 Gland Pharma
7.18.1 Gland Pharma Company Summary
7.18.2 Gland Pharma Business Overview
7.18.3 Gland Pharma Peptide Therapy Major Product Offerings
7.18.4 Gland Pharma Peptide Therapy Sales and Revenue in Global (2018-2023)
7.18.5 Gland Pharma Key News & Latest Developments
7.19 Troikaa Pharmaceuticals
7.19.1 Troikaa Pharmaceuticals Company Summary
7.19.2 Troikaa Pharmaceuticals Business Overview
7.19.3 Troikaa Pharmaceuticals Peptide Therapy Major Product Offerings
7.19.4 Troikaa Pharmaceuticals Peptide Therapy Sales and Revenue in Global (2018-2023)
7.19.5 Troikaa Pharmaceuticals Key News & Latest Developments
7.20 Biological E
7.20.1 Biological E Company Summary
7.20.2 Biological E Business Overview
7.20.3 Biological E Peptide Therapy Major Product Offerings
7.20.4 Biological E Peptide Therapy Sales and Revenue in Global (2018-2023)
7.20.5 Biological E Key News & Latest Developments
8 Global Peptide Therapy Production Capacity, Analysis
8.1 Global Peptide Therapy Production Capacity, 2018-2032
8.2 Peptide Therapy Production Capacity of Key Manufacturers in Global Market
8.3 Global Peptide Therapy Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Peptide Therapy Supply Chain Analysis
10.1 Peptide Therapy Industry Value Chain
10.2 Peptide Therapy Upstream Market
10.3 Peptide Therapy Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Peptide Therapy Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Peptide Therapy in Global Market
Table 2. Top Peptide Therapy Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Peptide Therapy Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Peptide Therapy Revenue Share by Companies, 2018-2023
Table 5. Global Peptide Therapy Sales by Companies, (K Units), 2018-2023
Table 6. Global Peptide Therapy Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Peptide Therapy Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Peptide Therapy Product Type
Table 9. List of Global Tier 1 Peptide Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Peptide Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Peptide Therapy Revenue, (US$, Mn), 2022 & 2032
Table 12. By Type - Global Peptide Therapy Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Peptide Therapy Revenue (US$, Mn), 2024-2032
Table 14. By Type - Global Peptide Therapy Sales (K Units), 2018-2023
Table 15. By Type - Global Peptide Therapy Sales (K Units), 2024-2032
Table 16. By Application ? Global Peptide Therapy Revenue, (US$, Mn), 2022 & 2032
Table 17. By Application - Global Peptide Therapy Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Peptide Therapy Revenue (US$, Mn), 2024-2032
Table 19. By Application - Global Peptide Therapy Sales (K Units), 2018-2023
Table 20. By Application - Global Peptide Therapy Sales (K Units), 2024-2032
Table 21. By Region ? Global Peptide Therapy Revenue, (US$, Mn), 2022 VS 2032
Table 22. By Region - Global Peptide Therapy Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Peptide Therapy Revenue (US$, Mn), 2024-2032
Table 24. By Region - Global Peptide Therapy Sales (K Units), 2018-2023
Table 25. By Region - Global Peptide Therapy Sales (K Units), 2024-2032
Table 26. By Country - North America Peptide Therapy Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Peptide Therapy Revenue, (US$, Mn), 2024-2032
Table 28. By Country - North America Peptide Therapy Sales, (K Units), 2018-2023
Table 29. By Country - North America Peptide Therapy Sales, (K Units), 2024-2032
Table 30. By Country - Europe Peptide Therapy Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Peptide Therapy Revenue, (US$, Mn), 2024-2032
Table 32. By Country - Europe Peptide Therapy Sales, (K Units), 2018-2023
Table 33. By Country - Europe Peptide Therapy Sales, (K Units), 2024-2032
Table 34. By Region - Asia Peptide Therapy Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Peptide Therapy Revenue, (US$, Mn), 2024-2032
Table 36. By Region - Asia Peptide Therapy Sales, (K Units), 2018-2023
Table 37. By Region - Asia Peptide Therapy Sales, (K Units), 2024-2032
Table 38. By Country - South America Peptide Therapy Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Peptide Therapy Revenue, (US$, Mn), 2024-2032
Table 40. By Country - South America Peptide Therapy Sales, (K Units), 2018-2023
Table 41. By Country - South America Peptide Therapy Sales, (K Units), 2024-2032
Table 42. By Country - Middle East & Africa Peptide Therapy Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Peptide Therapy Revenue, (US$, Mn), 2024-2032
Table 44. By Country - Middle East & Africa Peptide Therapy Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Peptide Therapy Sales, (K Units), 2024-2032
Table 46. Eli Lilly Company Summary
Table 47. Eli Lilly Peptide Therapy Product Offerings
Table 48. Eli Lilly Peptide Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Eli Lilly Key News & Latest Developments
Table 50. AstraZeneca Company Summary
Table 51. AstraZeneca Peptide Therapy Product Offerings
Table 52. AstraZeneca Peptide Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. AstraZeneca Key News & Latest Developments
Table 54. Merck Company Summary
Table 55. Merck Peptide Therapy Product Offerings
Table 56. Merck Peptide Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Merck Key News & Latest Developments
Table 58. Ipsen Company Summary
Table 59. Ipsen Peptide Therapy Product Offerings
Table 60. Ipsen Peptide Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Ipsen Key News & Latest Developments
Table 62. Novo Nordisk Company Summary
Table 63. Novo Nordisk Peptide Therapy Product Offerings
Table 64. Novo Nordisk Peptide Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Novo Nordisk Key News & Latest Developments
Table 66. Teva Pharmaceutical Industries Company Summary
Table 67. Teva Pharmaceutical Industries Peptide Therapy Product Offerings
Table 68. Teva Pharmaceutical Industries Peptide Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Teva Pharmaceutical Industries Key News & Latest Developments
Table 70. Abbott Laboratories Company Summary
Table 71. Abbott Laboratories Peptide Therapy Product Offerings
Table 72. Abbott Laboratories Peptide Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Abbott Laboratories Key News & Latest Developments
Table 74. Sanofi Company Summary
Table 75. Sanofi Peptide Therapy Product Offerings
Table 76. Sanofi Peptide Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Sanofi Key News & Latest Developments
Table 78. J & J Company Summary
Table 79. J & J Peptide Therapy Product Offerings
Table 80. J & J Peptide Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. J & J Key News & Latest Developments
Table 82. Novartis Company Summary
Table 83. Novartis Peptide Therapy Product Offerings
Table 84. Novartis Peptide Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. Novartis Key News & Latest Developments
Table 86. Takeda Company Summary
Table 87. Takeda Peptide Therapy Product Offerings
Table 88. Takeda Peptide Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 89. Takeda Key News & Latest Developments
Table 90. Ferring Company Summary
Table 91. Ferring Peptide Therapy Product Offerings
Table 92. Ferring Peptide Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 93. Ferring Key News & Latest Developments
Table 94. AbbVie Company Summary
Table 95. AbbVie Peptide Therapy Product Offerings
Table 96. AbbVie Peptide Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 97. AbbVie Key News & Latest Developments
Table 98. Heinis Company Summary
Table 99. Heinis Peptide Therapy Product Offerings
Table 100. Heinis Peptide Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 101. Heinis Key News & Latest Developments
Table 102. Hemmo Company Summary
Table 103. Hemmo Peptide Therapy Product Offerings
Table 104. Hemmo Peptide Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 105. Hemmo Key News & Latest Developments
Table 106. Emcure Pharmaceutical Company Summary
Table 107. Emcure Pharmaceutical Peptide Therapy Product Offerings
Table 108. Emcure Pharmaceutical Peptide Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 109. Emcure Pharmaceutical Key News & Latest Developments
Table 110. Cipla Company Summary
Table 111. Cipla Peptide Therapy Product Offerings
Table 112. Cipla Peptide Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 113. Cipla Key News & Latest Developments
Table 114. Gland Pharma Company Summary
Table 115. Gland Pharma Peptide Therapy Product Offerings
Table 116. Gland Pharma Peptide Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 117. Gland Pharma Key News & Latest Developments
Table 118. Troikaa Pharmaceuticals Company Summary
Table 119. Troikaa Pharmaceuticals Peptide Therapy Product Offerings
Table 120. Troikaa Pharmaceuticals Peptide Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 121. Troikaa Pharmaceuticals Key News & Latest Developments
Table 122. Biological E Company Summary
Table 123. Biological E Peptide Therapy Product Offerings
Table 124. Biological E Peptide Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 125. Biological E Key News & Latest Developments
Table 126. Peptide Therapy Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 127. Global Peptide Therapy Capacity Market Share of Key Manufacturers, 2021-2023
Table 128. Global Peptide Therapy Production by Region, 2018-2023 (K Units)
Table 129. Global Peptide Therapy Production by Region, 2024-2032 (K Units)
Table 130. Peptide Therapy Market Opportunities & Trends in Global Market
Table 131. Peptide Therapy Market Drivers in Global Market
Table 132. Peptide Therapy Market Restraints in Global Market
Table 133. Peptide Therapy Raw Materials
Table 134. Peptide Therapy Raw Materials Suppliers in Global Market
Table 135. Typical Peptide Therapy Downstream
Table 136. Peptide Therapy Downstream Clients in Global Market
Table 137. Peptide Therapy Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Peptide Therapy Segment by Type in 2022
Figure 2. Peptide Therapy Segment by Application in 2022
Figure 3. Global Peptide Therapy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Peptide Therapy Market Size: 2022 VS 2032 (US$, Mn)
Figure 6. Global Peptide Therapy Revenue, 2018-2032 (US$, Mn)
Figure 7. Peptide Therapy Sales in Global Market: 2018-2032 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Peptide Therapy Revenue in 2022
Figure 9. By Type - Global Peptide Therapy Revenue, (US$, Mn), 2022 & 2032
Figure 10. By Type - Global Peptide Therapy Revenue Market Share, 2018-2032
Figure 11. By Type - Global Peptide Therapy Sales Market Share, 2018-2032
Figure 12. By Type - Global Peptide Therapy Price (US$/Unit), 2018-2032
Figure 13. By Application - Global Peptide Therapy Revenue, (US$, Mn), 2022 & 2032
Figure 14. By Application - Global Peptide Therapy Revenue Market Share, 2018-2032
Figure 15. By Application - Global Peptide Therapy Sales Market Share, 2018-2032
Figure 16. By Application - Global Peptide Therapy Price (US$/Unit), 2018-2032
Figure 17. By Region - Global Peptide Therapy Revenue, (US$, Mn), 2022 & 2032
Figure 18. By Region - Global Peptide Therapy Revenue Market Share, 2018 VS 2022 VS 2032
Figure 19. By Region - Global Peptide Therapy Revenue Market Share, 2018-2032
Figure 20. By Region - Global Peptide Therapy Sales Market Share, 2018-2032
Figure 21. By Country - North America Peptide Therapy Revenue Market Share, 2018-2032
Figure 22. By Country - North America Peptide Therapy Sales Market Share, 2018-2032
Figure 23. US Peptide Therapy Revenue, (US$, Mn), 2018-2032
Figure 24. Canada Peptide Therapy Revenue, (US$, Mn), 2018-2032
Figure 25. Mexico Peptide Therapy Revenue, (US$, Mn), 2018-2032
Figure 26. By Country - Europe Peptide Therapy Revenue Market Share, 2018-2032
Figure 27. By Country - Europe Peptide Therapy Sales Market Share, 2018-2032
Figure 28. Germany Peptide Therapy Revenue, (US$, Mn), 2018-2032
Figure 29. France Peptide Therapy Revenue, (US$, Mn), 2018-2032
Figure 30. U.K. Peptide Therapy Revenue, (US$, Mn), 2018-2032
Figure 31. Italy Peptide Therapy Revenue, (US$, Mn), 2018-2032
Figure 32. Russia Peptide Therapy Revenue, (US$, Mn), 2018-2032
Figure 33. Nordic Countries Peptide Therapy Revenue, (US$, Mn), 2018-2032
Figure 34. Benelux Peptide Therapy Revenue, (US$, Mn), 2018-2032
Figure 35. By Region - Asia Peptide Therapy Revenue Market Share, 2018-2032
Figure 36. By Region - Asia Peptide Therapy Sales Market Share, 2018-2032
Figure 37. China Peptide Therapy Revenue, (US$, Mn), 2018-2032
Figure 38. Japan Peptide Therapy Revenue, (US$, Mn), 2018-2032
Figure 39. South Korea Peptide Therapy Revenue, (US$, Mn), 2018-2032
Figure 40. Southeast Asia Peptide Therapy Revenue, (US$, Mn), 2018-2032
Figure 41. India Peptide Therapy Revenue, (US$, Mn), 2018-2032
Figure 42. By Country - South America Peptide Therapy Revenue Market Share, 2018-2032
Figure 43. By Country - South America Peptide Therapy Sales Market Share, 2018-2032
Figure 44. Brazil Peptide Therapy Revenue, (US$, Mn), 2018-2032
Figure 45. Argentina Peptide Therapy Revenue, (US$, Mn), 2018-2032
Figure 46. By Country - Middle East & Africa Peptide Therapy Revenue Market Share, 2018-2032
Figure 47. By Country - Middle East & Africa Peptide Therapy Sales Market Share, 2018-2032
Figure 48. Turkey Peptide Therapy Revenue, (US$, Mn), 2018-2032
Figure 49. Israel Peptide Therapy Revenue, (US$, Mn), 2018-2032
Figure 50. Saudi Arabia Peptide Therapy Revenue, (US$, Mn), 2018-2032
Figure 51. UAE Peptide Therapy Revenue, (US$, Mn), 2018-2032
Figure 52. Global Peptide Therapy Production Capacity (K Units), 2018-2032
Figure 53. The Percentage of Production Peptide Therapy by Region, 2022 VS 2032
Figure 54. Peptide Therapy Industry Value Chain
Figure 55. Marketing Channels
